ARCHEMIN
0828.945.370 · rovalta.com · 22/09/2026
NORMAL SITUATION
ARCHEMIN
Financial year 2022 · closed on 31/12/2022
Net result
386,5 k €
+282.2% YoY
Gross margin
1,9 M €
+1.2% YoY
Equity
548,1 k €
+75.9% YoY
Workforce
16,2 ETP
+11.0% YoY
Company — Normal situation.
Overview
What does ARCHEMIN do?
ARCHEMIN is a company registered in Belgium. It employs on average 16,2 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0828.945.370
Legal form
Private company with limited liability
Contributed capital
18 600,00 €
Latest accounts
31/12/2022
Average workforce
16,2 ETP
Joint committees (2)
- 200
- 218
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 12 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||
| Gross margin | 1,9 M € | +1.2% | 1,9 M € | +20.6% | 1,5 M € | +7.1% | 1,4 M € | +8.8% | 1,3 M € | +48.8% | 891,3 k € | -5.6% | 944,3 k € | -0.4% | 947,9 k € | +28.8% | 736 k € | +6.9% | 688,2 k € | +23.2% | 558,4 k € | -4.2% | 583,1 k € |
| EBITDA | 509,7 k € | +10.0% | 463,5 k € | +1.7% | 455,9 k € | +52.2% | 299,7 k € | -35.5% | 464,8 k € | +75.4% | 265 k € | +33.8% | 198,1 k € | +0.0% | 198 k € | +488% | -51,1 k € | -191% | -17,6 k € | -158% | 30,5 k € | +445% | 5,6 k € |
| Operating result | 467,9 k € | +198% | 157 k € | -61.6% | 408,9 k € | +57.6% | 259,5 k € | -41.7% | 444,7 k € | +106% | 216 k € | +33.8% | 161,4 k € | -2.0% | 164,8 k € | +410% | -53,1 k € | -171% | -19,6 k € | -164% | 30,5 k € | +445% | 5,6 k € |
| Net result | 386,5 k € | +282% | 101,1 k € | -60.5% | 256,1 k € | +44.6% | 177,1 k € | -38.7% | 289,1 k € | +104% | 141,4 k € | +45.7% | 97,1 k € | -30.4% | 139,5 k € | +344% | -57,2 k € | -200% | -19,1 k € | -286% | 10,3 k € | +1994% | 489,7 € |
| Balance sheet | |||||||||||||||||||||||
| Equity | 548,1 k € | +75.9% | 311,6 k € | -65.8% | 910,5 k € | +39.1% | 654,4 k € | +37.1% | 477,3 k € | +44.2% | 331 k € | +74.6% | 189,6 k € | +105% | 92,5 k € | +297% | -47 k € | -559% | 10,2 k € | -65.1% | 29,3 k € | +53.7% | 19,1 k € |
| Total assets | 1,4 M € | +24.3% | 1,1 M € | -12.2% | 1,2 M € | -0.5% | 1,3 M € | +24.4% | 1 M € | +69.3% | 593,8 k € | +19.8% | 495,5 k € | +22.3% | 405,2 k € | +21.6% | 333,1 k € | +5.3% | 316,4 k € | -0.9% | 319,3 k € | +3.8% | 307,6 k € |
| Cash | 547,1 k € | +30.5% | 419,2 k € | -11.0% | 471,2 k € | -21.6% | 601,3 k € | +42.1% | 423,1 k € | +2724% | 15 k € | -77.0% | 65,1 k € | +15.3% | 56,5 k € | +363% | 12,2 k € | +919% | 1,2 k € | -91.8% | 14,6 k € | -71.5% | 51,3 k € |
| Debts | 553,5 k € | +5.5% | 524,6 k € | +56.7% | 334,8 k € | -43.9% | 596,5 k € | +12.9% | 528,3 k € | +101% | 262,8 k € | -14.1% | 305,9 k € | +3.6% | 295,2 k € | -9.9% | 327,6 k € | +7.0% | 306,1 k € | +5.6% | 290 k € | +27.5% | 227,4 k € |
| Other | |||||||||||||||||||||||
| Workforce | 16,2 ETP | +11.0% | 14,6 ETP | -2.0% | 14,9 ETP | +1.4% | 14,7 ETP | +13.1% | 13,0 ETP | +35.4% | 9,6 ETP | -12.7% | 11,0 ETP | +4.8% | 10,5 ETP | +5.0% | 10,0 ETP | +11.1% | 9,0 ETP | +23.3% | 7,3 ETP | -3.9% | 7,6 ETP |
Governance
Board of directors
Seen on filing of 31/12/2022 · 8 active · 4 ended
Active mandates
François De Witte
ActiveCaren Martini
ActiveCarolyn Belcher
ActiveLiza Lauberte
ActiveActive
Pharmalex France
ActiveSophie Dupont
ActiveThomas Dobmeyer
ActiveEnded mandates
Financials
Annual accounts
Full financial information
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/08/2023 | 29/08/2022 | 17/08/2021 | 30/09/2020 | 05/08/2019 | 23/08/2018 |
| General meeting | 26/05/2023 | 27/05/2022 | 28/05/2021 | 29/05/2020 | 31/05/2019 | 25/05/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
12 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2022 | 26/05/2023 | 29/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 27/05/2022 | 29/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 28/05/2021 | 17/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 29/05/2020 | 30/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 31/05/2019 | 05/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/05/2018 | 23/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/05/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/05/2016 | 27/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/05/2015 | 07/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/05/2014 | 08/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 26/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/05/2012 | 05/06/2012 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2022 · 8 active · 4 ended
Active mandates
François De Witte
ActiveCaren Martini
ActiveCarolyn Belcher
ActiveLiza Lauberte
ActiveActive
Pharmalex France
ActiveSophie Dupont
ActiveThomas Dobmeyer
ActiveEnded mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022386,5 k €↑
- 2021Annual accounts 2021101,1 k €↓
- 2020Annual accounts 2020256,1 k €↑
- 2019Annual accounts 2019177,1 k €↓
- 2018Annual accounts 2018289,1 k €↑
- 2017Annual accounts 2017141,4 k €↑
- 2016Annual accounts 201697,1 k €↓
- 2015Annual accounts 2015139,5 k €↑
- 2014Annual accounts 2014-57,2 k €↓
- 2013Annual accounts 2013-19,1 k €↓
- 2012Annual accounts 201210,3 k €↑
- 2011Annual accounts 2011489,7 €